These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21805408)

  • 1. Optimised patient transfer using an innovative multidisciplinary assessment in Kanton Aargau (OPTIMA I): an observational survey in lower respiratory tract infections.
    Albrich WC; Rüegger K; Dusemund F; Bossart R; Regez K; Schild U; Conca A; Schuetz P; Sigrist T; Huber A; Reutlinger B; Müller B
    Swiss Med Wkly; 2011; 141():w13237. PubMed ID: 21805408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm.
    Albrich WC; Dusemund F; Rüegger K; Christ-Crain M; Zimmerli W; Bregenzer T; Irani S; Buergi U; Reutlinger B; Mueller B; Schuetz P
    BMC Infect Dis; 2011 May; 11():112. PubMed ID: 21539743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proadrenomedullin improves Risk of Early Admission to ICU score for predicting early severe community-acquired pneumonia.
    Renaud B; Schuetz P; Claessens YE; Labarère J; Albrich W; Mueller B
    Chest; 2012 Dec; 142(6):1447-1454. PubMed ID: 22661450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TRIAGE-ProADM Score for an Early Risk Stratification of Medical Patients in the Emergency Department - Development Based on a Multi-National, Prospective, Observational Study.
    Kutz A; Hausfater P; Amin D; Amin A; Canavaggio P; Sauvin G; Bernard M; Conca A; Haubitz S; Struja T; Huber A; Mueller B; Schuetz P;
    PLoS One; 2016; 11(12):e0168076. PubMed ID: 28005916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial.
    Drozdov D; Thomer A; Meili M; Schwarz S; Kouegbe RB; Regez K; Guglielmetti M; Schild U; Conca A; Schäfer P; Reutlinger B; Ottiger C; Buchkremer F; Litke A; Schuetz P; Huber A; Bürgi U; Fux CA; Bock A; Müller B; Albrich WC;
    Trials; 2013 Mar; 14():84. PubMed ID: 23522152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker guided triage can reduce hospitalization rate in community acquired febrile urinary tract infection.
    Stalenhoef JE; van Nieuwkoop C; Wilson DC; van der Starre WE; Delfos NM; Leyten EMS; Koster T; Ablij HC; Van't Wout JJW; van Dissel JT
    J Infect; 2018 Jul; 77(1):18-24. PubMed ID: 29807091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study.
    Odermatt J; Meili M; Hersberger L; Bolliger R; Christ-Crain M; Briel M; Bucher HC; Mueller B; Schuetz P
    BMC Cardiovasc Disord; 2017 Jul; 17(1):178. PubMed ID: 28676115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial.
    Albrich WC; Rüegger K; Dusemund F; Schuetz P; Arici B; Litke A; Blum CA; Bossart R; Regez K; Schild U; Guglielmetti M; Conca A; Schäfer P; Schubert M; de Geest S; Reutlinger B; Irani S; Bürgi U; Huber A; Müller B
    Eur Respir J; 2013 Oct; 42(4):1064-75. PubMed ID: 23349444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red blood cell distribution width [RDW] and long-term mortality after community-acquired pneumonia. A comparison with proadrenomedullin.
    Bello S; Fandos S; Lasierra AB; Mincholé E; Panadero C; Simon AL; Gavin O; De Pablo F; Menendez R; Torres A
    Respir Med; 2015 Sep; 109(9):1193-206. PubMed ID: 26205553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections.
    Schuetz P; Wolbers M; Christ-Crain M; Thomann R; Falconnier C; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Morgenthaler NG; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
    Crit Care; 2010; 14(3):R106. PubMed ID: 20529344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers from distinct biological pathways improve early risk stratification in medical emergency patients: the multinational, prospective, observational TRIAGE study.
    Schuetz P; Hausfater P; Amin D; Amin A; Haubitz S; Faessler L; Kutz A; Conca A; Reutlinger B; Canavaggio P; Sauvin G; Bernard M; Huber A; Mueller B;
    Crit Care; 2015 Oct; 19():377. PubMed ID: 26511878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential impact of biomarker-guided triage decisions for patients with urinary tract infections.
    Litke A; Bossart R; Regez K; Schild U; Guglielmetti M; Conca A; Schäfer P; Reutlinger B; Mueller B; Albrich WC
    Infection; 2013 Aug; 41(4):799-809. PubMed ID: 23435720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia.
    Schuetz P; Litke A; Albrich WC; Mueller B
    Curr Opin Infect Dis; 2013 Apr; 26(2):159-67. PubMed ID: 23434895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker-guided personalised emergency medicine for all - hope for another hype?
    Schuetz P; Aujesky D; Müller C; Müller B
    Swiss Med Wkly; 2015; 145():w14079. PubMed ID: 25695147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology.
    Bello S; Lasierra AB; Mincholé E; Fandos S; Ruiz MA; Vera E; de Pablo F; Ferrer M; Menendez R; Torres A
    Eur Respir J; 2012 May; 39(5):1144-55. PubMed ID: 22075489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic performance of MR-pro-adrenomedullin in patients with community acquired pneumonia in the Emergency Department compared to clinical severity scores PSI and CURB.
    Legramante JM; Mastropasqua M; Susi B; Porzio O; Mazza M; Miranda Agrippino G; D Agostini C; Brandi A; Giovagnoli G; Di Lecce VN; Bernardini S; Minieri M
    PLoS One; 2017; 12(11):e0187702. PubMed ID: 29161297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in lower respiratory tract infections.
    Blasi F; Stolz D; Piffer F
    Pulm Pharmacol Ther; 2010 Dec; 23(6):501-7. PubMed ID: 20434579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent Cox regression: serial measurement of the cardiovascular biomarker proadrenomedullin improves survival prediction in patients with lower respiratory tract infection.
    Hartmann O; Schuetz P; Albrich WC; Anker SD; Mueller B; Schmidt T
    Int J Cardiol; 2012 Nov; 161(3):166-73. PubMed ID: 23017815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia.
    Courtais C; Kuster N; Dupuy AM; Folschveiller M; Jreige R; Bargnoux AS; Guiot J; Lefebvre S; Cristol JP; Sebbane M
    Am J Emerg Med; 2013 Jan; 31(1):215-21. PubMed ID: 23000327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Proadrenomedullin Enhanced CURB65 Score Algorithm in Patients with Community-Acquired Pneumonia in "Real Life", an Observational Quality Control Survey.
    Widmer D; Drozdov D; Rüegger K; Litke A; Arici B; Regez K; Guglielmetti M; Schild U; Conca A; Schäfer P; Kouegbe RB; Reutlinger B; Blum C; Schuetz P; Irani S; Huber A; Bürgi U; Müller B; Albrich WC
    J Clin Med; 2014 Mar; 3(1):267-79. PubMed ID: 26237261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.